Hilkka Soininen

Active 1982–2025

351
Papers
61,657
Citations
136
h-index
337
i10-index

Citations

Citations per year for Hilkka Soininen1949: 1 citations1957: 3 citations1958: 1 citations1977: 1 citations1979: 2 citations1982: 3 citations1983: 2 citations1984: 7 citations1985: 8 citations1986: 8 citations1987: 9 citations1988: 17 citations1989: 14 citations1990: 18 citations1991: 18 citations1992: 24 citations1993: 20 citations1994: 28 citations1995: 22 citations1996: 39 citations1997: 76 citations1998: 92 citations1999: 110 citations2000: 150 citations2001: 197 citations2002: 239 citations2003: 266 citations2004: 329 citations2005: 359 citations2006: 369 citations2007: 432 citations2008: 507 citations2009: 543 citations2010: 631 citations2011: 668 citations2012: 724 citations2013: 816 citations2014: 893 citations2015: 802 citations2016: 865 citations2017: 841 citations2018: 823 citations2019: 2,173 citations2020: 2,366 citations2021: 2,405 citations2022: 1,963 citations2023: 1,477 citations2024: 2,120 citations2025: 1,027 citations2026: 50 citations1950–1956: no citations, so these years are not shown1959–1976: no citations, so these years are not shown1978: no citations, so this year is not shown1980–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,577 citing papers, 23.7% of this breakdownUnited Kingdom: 2,972 citing papers, 9.3% of this breakdownChina: 2,282 citing papers, 7.1% of this breakdownGermany: 1,480 citing papers, 4.6% of this breakdownSweden: 1,447 citing papers, 4.5% of this breakdownItaly: 1,345 citing papers, 4.2% of this breakdownCanada: 1,244 citing papers, 3.9% of this breakdownNetherlands: 1,153 citing papers, 3.6% of this breakdownAustralia: 1,121 citing papers, 3.5% of this breakdownFrance: 1,112 citing papers, 3.5% of this breakdownSpain: 1,077 citing papers, 3.4% of this breakdownFinland: 787 citing papers, 2.5% of this breakdown
0%23.7%Other 26.2%

Fields

  • Medicine61.2%
  • Neuroscience17.6%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Computer Science3.1%
  • Psychology1.8%
  • Nursing0.9%
  • Other4.5%

Topics

  • Alzheimer's disease research and treatments11.8%
  • Dementia and Cognitive Impairment Research11.8%
  • Functional Brain Connectivity Studies3.1%
  • Neuroinflammation and Neurodegeneration Mechanisms2.3%
  • Neurological Disease Mechanisms and Treatments2%
  • Cholinesterase and Neurodegenerative Diseases1.7%
  • Other67.3%

Coauthors

All papers

Open in search
  1. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet 2015 cited by 3,603

  2. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2019 cited by 573

  3. Common brain disorders are associated with heritable patterns of apparent aging of the brain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lena Flyckt, Barbara Franke, Oleksandr Frei, Beathe Haatveit, Asta K. Håberg, Hanne F. Harbo, Catharina A. Hartman, Dirk J. Heslenfeld, Pieter J. Hoekstra, Einar August Høgestøl, Terry L. Jernigan, Rune Jonassen, Erik G. Jönsson, Peter Kirsch, Iwona Kłoszewska, Knut K. Kolskår, Nils Inge Landrø, Stéphanie Le Hellard, Klaus‐Peter Lesch, Simon Lovestone, Arvid Lundervold, Astri J. Lundervold, Luigi A. Maglanoc, Ulrik Fredrik Malt, Patrizia Mecocci, Ingrid Melle, Andreas Meyer‐Lindenberg, Torgeir Moberget, Linn B. Norbom, Jan Egil Nordvik, Lars Nyberg, Jaap Oosterlaan, Marco Papalino, Andreas Papassotiropoulos, Paul Pauli, Giulio Pergola, Karin Persson, Geneviève Richard, Jaroslav Rokicki, Anne‐Marthe Sanders, Geir Selbæk, Alexey Shadrin, Olav B. Smeland, Hilkka Soininen, Piotr Sowa, Vidar M. Steen, Magda Tsolaki, Kristine M. Ulrichsen, Bruno Vellas, Lei Wang, Eric Westman, Georg Ziegler, Mathias Zink, Ole A. Andreassen, Lars T. Westlye - Nature Neuroscience 2019 cited by 617

  4. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paolo Bosco, Michelangelo Mancuso, Francesco Panza, Benedetta Nacmias, Paola Bossù, Paola Piccardi, Giorgio Annoni, Davide Seripa, Daniela Galimberti, Didier Hannequin, Federico Licastro, Hilkka Soininen, Karen Ritchie, Hélène Blanché, Jean‐François Dartigues, Christophe Tzourio, Marta Gut, Christine Van Broeckhoven, Annick Alpérovitch, Mark Lathrop, Philippe Amouyel - Nature Genetics 2009 cited by 2,271

  5. World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jee Hyang Jeong, Gustavo Jimenez‐Maggiora, Edward H. Koo, Lenore J. Launer, Jenni Lehtisalo, Francisco Lopera, Pablo Martínez‐Lage, Ralph N. Martins, Lefkos Middleton, José Luís Molinuevo, Manuel Montero‐Odasso, So Young Moon, Kristal Morales‐Pérez, Ricardo Nitríni, Haakon B. Nygaard, Yoo K. Park, Markku Peltonen, Chengxuan Qiu, Yakeel T. Quiroz, Rema Raman, Naren P. Rao, Vijayalakshmi Ravindranath, Anna Rosenberg, Takashi Sakurai, Rosa María Salinas, Philip Scheltens, Gustavo Sevlever, Hilkka Soininen, Ana Luisa Sosa, Cláudia Kimie Suemoto, Mikel Tainta, Lina Velilla, Yongxiang Wang, Rachel A. Whitmer, Xin Xu, Lisa J. Bain, Alina Solomon, Tiia Ngandu, María C. Carrillo - Alzheimer s & Dementia 2020 cited by 521

  6. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2021 cited by 351

  7. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study

    Authors: , , , , , - The Lancet Neurology 2006 cited by 1,135

  8. APOE and Alzheimer disease: a major gene with semi-dominant inheritance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandro Sorbi, Gianfranco Spalletta, Fernando Valdivieso, Saila Vepsäläinen, Victoria Álvarez, Paolo Bosco, Michelangelo Mancuso, Francesco Panza, Benedetta Nacmias, Paola Bossù, Olivier Hanon, Paola Piccardi, G Annoni, Davide Seripa, Daniela Galimberti, Federico Licastro, Hilkka Soininen, Dartigues Jf, M. Ilyas Kamboh, Christine Van Broeckhoven, Jean‐Charles Lambert, Philippe Amouyel, Dominique Campion - Molecular Psychiatry 2011 cited by 703

  9. The reliability of a deep learning model in clinical out-of-distribution MRI data: a multicohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Medical Image Analysis 2020 cited by 171

  10. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial

    Authors: , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2017 cited by 425

  11. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress

    Authors: , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2013 cited by 583

  12. Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease

    Authors: , , , , , , , , , - Archives of Neurology 2005 cited by 1,288

  13. Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

    Authors: , , , , , , - Archives of Neurology 2009 cited by 897

  14. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome

    Authors: , , , , , , - Progress in Neurobiology 2013 cited by 361

  15. Targeting Prodromal Alzheimer Disease With Avagacestat

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2015 cited by 233

  16. Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Sánchez‐Valle, Victoria Álvarez, Merçé Boada, Pablo García‐González, Raquel Puerta, Pablo Mir, Luís Miguel Real, Gerard Piñol‐Ripoll, José María García‐Alberca, José Luís Royo, Eloy Rodríguez‐Rodríguez, Hilkka Soininen, Teemu Kuulasmaa, Alexandre de Mendonça, Shima Mehrabian, Jakub Hort, Martin Vyhnálek, Sven J. van der Lee, Caroline Graff, Goran Papenberg, Vilmantas Giedraitis, Anne Boland, Delphine Bacq‐Daian, Jean‐François Deleuze, Gaël Nicolas, Carole Dufouil, Florence Pasquier, Olivier Hanon, Stéphanie Debette, Edna Grünblatt, Julius Popp, Luisa Benussi, Daniela Galimberti, Beatrice Arosio, Patrizia Mecocci, Vincenzo Solfrizzi, Lucilla Parnetti, Alessio Squassina, Lucio Tremolizzo, Barbara Borroni, Benedetta Nacmias, Sandro Sorbi, Paolo Caffarra, Davide Seripa, Innocenzo Rainero, Antonio Daniele, Carlo Masullo, Gianfranco Spalletta, Julie Williams, Philippe Amouyel, Frank Jessen, Patrick G. Kehoe, Magda Tsolaki, Giacomina Rossi, Pascual Sánchez‐Juan, Kristel Sleegers, Martin Ingelsson, Ole A. Andreassen, Mikko Hiltunen, Cornelia M. van Duijn, Rebecca Sims, Wiesje M. van der Flier, Agustı́n Ruiz, Alfredo Ramı́rez, Jean‐Charles Lambert, Ruth Frikke‐Schmidt - JAMA Network Open 2023 cited by 93

  17. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ruth Frikke‐Schmidt, Julie Williams, Agustı́n Ruiz, Jean‐Charles Lambert, Michael D. Greicius, Members of the EADB, GR@ACE, DEGESCO, DemGene, GERAD, and EADI Groups, Beatrice Arosio, Luisa Benussi, Anne Boland, Barbara Borroni, Paolo Caffarra, Delphine Daian, Antonio Daniele, Stéphanie Debette, Carole Dufouil, Emrah Düzel, Daniela Galimberti, Vilmantas Giedraitis, Timo Grimmer, Caroline Graff, Edna Grünblatt, Olivier Hanon, Lucrezia Hausner, Stefanie Heilmann‐Heimbach, Henne Holstege, Jakub Hort, Jürgen Deckert, Teemu Kuulasmaa, Aad van der Lugt, Carlo Masullo, Patrizia Mecocci, Shima Mehrabian, Alexandre de Mendonça, Susanne Moebus, Benedetta Nacmias, Gaël Nicolas, Robert Olaso, Goran Papenberg, Lucilla Parnetti, Florence Pasquier, Oliver Peters, Yolande A.L. Pijnenburg, Julius Popp, Innocenzo Rainero, Inez Ramakers, Steffi G. Riedel‐Heller, Nikolaos Scarmeas, Philip Scheltens, Norbert Scherbaum, Anja Schneider, Davide Seripa, Hilkka Soininen, Vincenzo Solfrizzi, Gianfranco Spalletta, Alessio Squassina, John C. van Swieten, Thomas Tegos, Lucio Tremolizzo, Frans Verhey, Martin Vyhnálek, Jens Wiltfang, Merçé Boada, Pablo García‐González, Raquel Puerta, Luís Miguel Real, Victoria Álvarez, María J. Bullido, Jordi Clarimón, José María García‐Alberca, Pablo Mir and 10 more - JAMA Neurology 2022 cited by 93

  18. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

    Authors: , , , , , , , , - BMJ 2001 cited by 1,612

  19. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2018 cited by 210

  20. Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Lemos, Sebastiaan Engelborghs, Stefan Van der Mussele, The Alzheimer’s Disease Neuroimaging Initiative, Yvonne Freund‐Levi, Åsa K. Wallin, Harald Hampel, Wiesje M. van der Flier, Philip Scheltens, Pieter Jelle Visser - Brain 2015 cited by 393

  21. Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pálmi V. Jónsson, Sigurbjörn Björnsson, Jón Snædal, Kari Stefansson - Nature Genetics 2015 cited by 332

  22. Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , - Alzheimer s Research & Therapy 2021 cited by 120

  23. Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Archives of Neurology 2012 cited by 369

  24. Heterogeneous patterns of brain atrophy in Alzheimer's disease

    Authors: , , , , , , , , , , - Neurobiology of Aging 2018 cited by 175